Metacam Injection 20mg

Description

Buy Metacam Injection 20mg  solution for injection for cattle, pigs and horses 50 ml For use in acute respiratory infection, diarrhoea, in the treatment of acute mastitis, in the relief of post-operative pain (cattle) in non-infectious locomotor disorders, in the treatment of puerperal septicaemia and toxaemia (pigs)

    Buy Metacam Injection 20mg

Metacam 40mg/ml solution for injection for cattle and horses contains 40mg/ml of meloxicam and is available in either 50ml or 100ml presentations.

Metacam 40mg/ml is approved for SC or IV use in cattle, and IV use in horses following a positive opinion from the European Medicines Agency.

Research data

The introduction follows a large-scale landmark study that found, when compared to cows receiving antibiotic therapy alone, adding Metacam to standard antibiotic therapy for mastitis resulted in:

• a greater first service conception rate
• fewer inseminations required to conceive
• a higher probability of pregnancy by 120 days post-calving

Welfare improvements

Boehringer technical manager Kath Aplin said: “By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes.

“This is central to efficient herd management and productivity.”

The Metacam 40mg/ml formulation offers a lower volume dose compared to the existing 20mg/ml presentation, giving vets more flexibility in their use of Metacam, the manufacturer claims.

Metacam Injection 20mg  solution for injection for cattle, pigs and horses 50 ml For use in acute respiratory infection, diarrhoea, in the treatment of acute mastitis, in the relief of post-operative pain (cattle) in non-infectious locomotor disorders, in the treatment of puerperal septicaemia and toxaemia (pigs)

Metacam 40mg/ml solution for injection for cattle and horses contains 40mg/ml of meloxicam and is available in either 50ml or 100ml presentations.

Metacam 40mg/ml is approved for SC or IV use in cattle, and IV use in horses following a positive opinion from the European Medicines Agency.

Research data

The introduction follows a large-scale landmark study that found, when compared to cows receiving antibiotic therapy alone, adding Metacam to standard antibiotic therapy for mastitis resulted in:

• a greater first service conception rate
• fewer inseminations required to conceive
• a higher probability of pregnancy by 120 days post-calving

Welfare improvements

Boehringer technical manager Kath Aplin said: “By reducing the pain and inflammation caused by mastitis and other conditions, the use of Metacam 40 can result in improvements in cattle health and welfare, and may help limit any reduction in feed intakes.

“This is central to efficient herd management and productivity.”

The Metacam 40mg/ml formulation offers a lower volume dose compared to the existing 20mg/ml presentation, giving vets more flexibility in their use of Metacam, the manufacturer claims.